2014
DOI: 10.1016/b978-0-12-800097-7.00005-1
|View full text |Cite
|
Sign up to set email alerts
|

Reprogramming and Carcinogenesis—Parallels and Distinctions

Abstract: Abbreviations: CDK -Cyclin-Dependent Kinase; CSC -cancer stem cells; DSB -double strand breaks ; ECM -extracellular matrix; ES cell -embryonic stem cell; GFP -green fluorescent protein; GSK3 -glycogen synthase kinase-3; HN -Hemagglutininneuraminidase; iPS -induced pluripotent stem cells; MSFs -myocardial scar fibroblasts; RB -Retinoblastoma protein; RGD -arginine-glycine-aspartic acid; RISC -RNA-induced silencing complex; Shc -Src homology 2 domain-containing.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
41
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 49 publications
(42 citation statements)
references
References 176 publications
0
41
0
Order By: Relevance
“…1,2 The origin of CSCs is still debated. They may either originate from normal (tissue) stem cells or form in a process similar to reprogramming (dedifferentiation).…”
Section: Introductionmentioning
confidence: 99%
“…1,2 The origin of CSCs is still debated. They may either originate from normal (tissue) stem cells or form in a process similar to reprogramming (dedifferentiation).…”
Section: Introductionmentioning
confidence: 99%
“…Like in some other diseases (Likus et al 2016a), it is however sometimes difficult to clearly associate the given pathogen with cancer etiology. Many viruses preferentially or exclusively replicate in dividing cells; hence, their components are potentially becoming an important source/inspiration in the search of drugs that preferentially target cancer stem cells (AkbariBirgani et al 2016;Farahani et al 2014;Wasik et al 2014). Beside viral methods, some clinically tested as well as new drugs with preferential toxicity towards cancer stem cells are increasingly becoming available (Jangamreddy et al 2013;Likus et al 2016b;Moosavi et al 2016).…”
Section: Discussionmentioning
confidence: 99%
“…Another problem is the long period for full iPSC reprogramming and the high cells proliferation rates associated with a greater chance of developing cancer. 71 Takahashi and Yamanaka suggest considering using iPSC with allogeneic transplantation in regenerative medicine, which would improve the effectiveness of the treatment of certain diseases such as spinal cord injury, which requires quick treatment without waiting for the time taken for reprogramming. 11 Furthermore, there is a need for better understanding of how the reprogramming interventions influence the epigenetic memory of the reprogrammed cells.…”
Section: Resultsmentioning
confidence: 99%